IGC Pharma, Inc. (IGC)
0.3492
+0.05
(+17.18%)
USD |
NYAM |
Dec 10, 16:00
0.3542
0.00 (0.00%)
After-Hours: 17:35
IGC Pharma Profit Margin (Quarterly): -953.4% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Esperion Therapeutics, Inc. | -35.89% |
| Theravance Biopharma, Inc. | 18.08% |
| NRX Pharmaceuticals, Inc. | -2.43K% |
| CEL-SCI Corp. | -- |
| AIM ImmunoTech, Inc. | -12.63K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -94.42% |
| Return on Assets | -70.25% |
| Return on Invested Capital | -91.27% |
| Gross Profit Margin (Quarterly) | -3.14% |
| Operating Margin (Quarterly) | -1.52K% |
| Return on Net Operating Assets | -91.95% |